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httpcense.Abstract Predictors of in-hospital mortality and need for invasive mechanical ventilation (IMV) in
chronic obstructive pulmonary disease (COPD) patients presenting with acute hypercapnic respira-
tory failure (AHRF) are yet lacking, but warranted in elderly population. Formulating a scoring
system may aid prognostication.
A prospective study including all elderly patients with COPD and AHRF admitted to a Geriatric
and Respiratory ICU over one year period. Different clinical and laboratory variables were
recorded at the time of admission and were compared between IMV and non-IMV patients and sur-
vivor and non-survivor patients upon discharge.
Thirty patients were enrolled. Mean (SD) age of patients was 68.2 ± 7.95; 56.7% had IMV. The
inhospital morality was 13.3% all of whom died in ICU and had IMV. Renal impairment, previous
history of hypertension, pneumonia, sepsis and lower glucose level were signiﬁcant predictors of
mortality and discriminant equation for the prediction of mortality had accuracy for the area under
ROC curve of 94.2% having sensitivity, speciﬁcity, positive and negative predictive values for pre-ve pulmonary diseases; IMV,
acute hypercapnic respiratory
of COPD; ROC, Receiver
stay.
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394 A.M. Madkour, N.N. Adlydicting death of 100%, 89%, 57% and 100%, respectively. Sepsis, pack year smoking, severe cur-
rent exacerbation, Simpliﬁed Acute Physiology Scores II and lower pH were signiﬁcant predictors
of IMV and discriminant equation for the prediction of IMV had accuracy of 87.8% for the area
under ROC curve having sensitivity, speciﬁcity, positive and negative predictive values for predict-
ing need for IMV of 76%, 92%, 93% and 75%, respectively.
The equations derived by combining these parameters are useful for identifying patients that are
likely to have a poor outcome or need for IMV.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
Open access under CC BY-NC-ND license.Introduction
Life expectancy has signiﬁcantly increased over the last
30 years with an increasing incidence of age-related and
aging-related clinical conditions, in particular chronic obstruc-
tive pulmonary disease (COPD) [1]. COPD is a common dis-
ease in older adults, affecting 14.2% of elderly individuals
[2]. It is responsible for 19.9% of hospitalizations of adults
aged 65–75 [3]. The clinical course of patients with acute exac-
erbations of underlying COPD and hypercapnic respiratory
failure has not been fully characterized [4]. However, the re-
ported morality rate for COPD presenting with acute hyper-
capnic respiratory failure (AHRF) varies between 6% and
24% [4–8]. These rates increase to 14–57% as ventilatory sup-
port becomes inevitable [8–10].
Determining the factors predicting poor outcome and need
for invasive mechanical ventilation (IMV) are of interest to
intensivists, because early identiﬁcation of patients at high risk
is essential, as well as tailoring monitoring, therapy and coun-
seling families [8].
Many prognostic scoring systems have been created for the
prediction of patient outcome. General illness severity scores
were developed to be used in mixed groups of ICU patients
and their accuracy in subgroups of patients can be questioned
[11]. Disease-speciﬁc prognostic scoring systems are needed.
Many factors have been identiﬁed as predictors of ICU
mortality [6–9,12] in patients with COPD including age and
AHRF. Many studies [12–16] have demonstrated age to be
correlated with mortality among COPD patients receiving
IMV. Yet other studies reported that age was not an indepen-
dent predictor of COPD outcome [10,17]. AHRF has a signif-
icant effect on prognosis in patients with COPD [18,19].
Although COPD is a common reason for hospital admission
in our elderly population, little has been documented about this
problem from Egypt. Especially regarding in-hospital mortality
andneed for IMV in elderly EgyptianCOPDpatients presenting
withAHRF. There is a need to develop a simple and inexpensive
prognostic scoring system for such patients.
Keeping these factors in mind, the present study was de-
signed to prospectively determine predictors of in-hospital
mortality and need for IMV in elderly COPD patients present-
ing with AHRF.Materials and methods
Study population
This study was carried out in the Geriatric and Respiratory
ICU (GICU & RICU) at the Ain Shams University hospital,elderly patients (P60 years) admitted for acute exacerbation
of COPD (AECOPD) with AHRF were recruited during the
period between June 2011 and June 2012.
The diagnosis of COPD was determined by the premor-
bid pulmonary function testing when available within 2 years
of hospital admission based on Global Initiative for Chronic
Obstructive Lung Disease guideline, 2010 [20]. Since COPD
patients with AHRF were sustaining severe bronchial
obstruction, and their general status did not give permission,
physiologic assessment with pulmonary function tests could
not be performed in all patients. In the absence of docu-
mented airﬂow obstruction, clinical criteria used were, clini-
cal history with compatible physical ﬁndings, and/or
evidence of hyperinﬂation on chest radiograph, interpreted
by attending physicians, in support of the diagnosis of
COPD, as described in the 1995 statement from the Ameri-
can Thoracic Society [21]. AECOPD was determined by in-
creased dyspnea, sputum volume and/ or purulence, beyond
day-to-day variations to the extent that changes in therapy
were warranted [22].
AHRF was deﬁned by arterial blood gas criteria (partial
pressure of carbon dioxide: PaCO2 > 45 mmHg and
pH< 7.35) [23].
The patients with acute respiratory distress syndrome, pul-
monary embolism, malignancy, respiratory failure due to rea-
sons other than COPD and COPD without hypercapnia were
excluded. Those who died within the ﬁrst 24 h following
admission to the ICU or receiving noninvasive ventilation were
also excluded form study.
Data collection
Patients’ characteristics were recorded during the ﬁrst 24 h of
ICU admission. These included age, sex, smoking history,
dyspnea grade (according to Medical Research Council
dyspnea scale) [24], number of exacerbations in the last year,
current exacerbation severity (according to Anthonisen AE-
COPD types) [25], vital data, arrhythmia, urinary output,
length of stay (LOS) in hospital and ICU, current and previous
IMV occurrence, duration of IMV, Simpliﬁed Acute Physiol-
ogy Scores II (SAPS II), Glasgow Coma Score (GCS), multiple
organ failure, co-morbid diseases and physical examination
ﬁndings on admission.
All necessary laboratory results during the ﬁrst 24 h of
ICU admission were recorded [complete blood count, so-
dium (mEq/l), potassium (mEq/l), creatinine (mg/dl), blood
urea nitrogen (BUN) (mg/dl), bilirubin (mg/dl), glucose
(mg/dl), albumin (mg/dl), SGOT (IU/L) and SGPT (IU/
L)]. In addition, microbiological cultures for sputum or
endotracheal tube aspirate, chest X-ray, arterial blood gases
Table 1 Descriptive proﬁle of the study group (n= 30).
Variables Results
Age and sex
Mean age 68.2 ± 7.95
Age (60–70 years) No. (%) 16 (53.3%)
Age (P70 years) No. (%) 14 (46.7%)
Sex (male) No. (%) 21 (70%)
Clinical variables
Dyspneab (grade 3) No. (%) 6 (20%)
Dyspneab (grade 4) No. (%) 17 (56.7%)
Current exacerbationc (moderate) No. (%) 7 (23.3%)
Current exacerbationc (severe) No. (%) 18 (60%)
Number of exacerbations last yeara 2.55 ± 0 .1
Pack/year smoking 61.4 ± 37.7
Heart rate 100 ± 1.8
Respiratory rate 27.5 ± 5.3
Temperature 37.4±.67
Systolic blood pressure 130 ± 2.1
Diastolic blood pressurea 80 ± 11.4
Arrhythmia No. (%) 4 (13.3%)
Urinary out put 1863 ± 756
Length of stay in hospital (days) 14.1 ± 8.9
Length of stay in ICU (days)a 9.9 ± 7.9
Previous mechanical ventilation No. (%) 8 (28.7%)
Current IMV No. (%) 17 (56.7%)
IMV durationa 4.4 ± 7.5
Arterial blood gases
FiO2
a 0.26 ± .09
PH 7.26 ± 0 .07
PaCO2 mmHg 81.2 ± 1.8
PaO2 mmHg 57.87 ± 3.1
HCO3
 36.59 ± 8.2
Oxygen saturation%a 77.95 ± 15.5
PaO2/FiO2
a 235.5 ± 137.5
Scores
Glasgow Coma Scorea 14.46 ± 1.8
SAPS II 31.6 ± 6.9
Sepsis No. (%) 4 (13.3)
MOF No. (%) 1 (3.3%)
Mortality No. (%) 4 (13.3%)
Data are presented as mean ± SD unless otherwise indicated.
IMV: invasive mechanical ventilation; FiO2: fraction of inspired
oxygen; PaO2: partial arterial oxygen pressure; PaCO2: partial
arterial carbon dioxide pressure; pH: arterial blood pH; HCO3
:
bicarbonate; SAPS II: Simpliﬁed Acute Physiology Scores II; GCS:
Glasgow Coma Score, MOF: Multiple organ failure.
a Non parametric data were converted into parametric by log
transformation and mean ± SD of the original data was expressed.
b Dyspnea grade is according to Medical Research Council
(MRC) dyspnea scale [24].
c Current exacerbation severity is according to Anthonisen
AECOPD types [25].
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mortality and survival status upon hospital discharge were
documented.
The treatment of COPD applied in ICU is according to the
international standard of practice guidelines [20,22]. Criteria
for intubation and weaning used were according to what was
previously stated in detail by Pierson, 2004 [26].
Statistical analysis
All results were collected, tabulated and statically analyzed
using appropriate statistical methods. Description of data
was expressed in form of mean ± SD for quantitative data
or number and frequency for qualitative data. Qualitative data
were compared using Chi-square or Fisher’s exact when appro-
priate. Non parametric quantitative data were converted into
parametric by log transformation and mean ± SD of the ori-
ginal data was expressed. Quantitative data were compared
using two samples t-test. Discriminate analysis was performed
to compute equations that could predict mortality and IMV.
Receiver operator characteristic (ROC) curve for each pre-
dicted equation was done, in the presence of signiﬁcant area
under curve (AUC); best cut-off, sensitivity, speciﬁcity, posi-
tive predicted value (PPV), and negative predicted value
(NPV) were calculated. P-Values less than 0.05 were regarded
as a sign of statistical signiﬁcance. All data analyses were per-
formed using the 16th version of SPSS.
Results
Thirty elderly COPD patients presenting with AHRF who ful-
ﬁlled the study inclusion criteria were enrolled. The descriptive
proﬁle of the study group is presented in Table 1. The in-hospi-
tal morality was 13.3% all of whom died in ICU and had IMV.
Patients’ characteristics with regard to mortality end point
and IMV are shown in Table 2. There was a signiﬁcant differ-
ence between survivors and non-survivors regarding the LOS
in hospital and duration of IMV. Patients in the non survival
group had a longer LOS in hospital and IMV duration. There
was a signiﬁcant difference between IMV and non-IMV pa-
tients regarding the severe current exacerbation occurrence,
LOS in hospital, duration of IMV, arterial blood pH, bicar-
bonate and SAPS II scores. Patients on IMV had a more se-
vere current exacerbation, longer LOS in hospital and IMV
duration, lower pH and bicarbonate (HCO3
), and higher
SAPS II scores (Table 2).
There was no signiﬁcant difference between survivors and
non-survivors as well as IMV and non-IMV patients regarding
different co-morbidities (hypertension, diabetes, heart disease)
studied except patients with renal impairment were signiﬁ-
cantly more in survivor than non-survivor patients (P= 0.01).
There was no signiﬁcant difference between survivor and
non-survivor and IMV and non-IMV patients regarding the
studied different laboratory results; except patients with posi-
tive IMV had a signiﬁcant lower glucose level (P= 0.008).
The mean blood glucose level was 140 mg/dl and 81 mg/dl in
survivor and non- survivor patients respectively (P
value = 0.008).
The discriminant analysis (DA) showed that sepsis, pack
year smoking, severe current exacerbation, SAPS II and lowerpH were signiﬁcant predictors of IMV and discriminant equa-
tion for prediction of IMV was constructed (Table 3).
ROC curve was plotted for studying the accuracy of the pre-
dicted equation in prediction of IMV and result is shown
(Fig. 1). ROC curve showed that the predicted equation has a
moderate predictive capability with area under the ROC curve
(AUC) of 0.878 with a cut-off ofP1.1728 having sensitivity,
Table 2 Differences in patient characteristics between survivors and non-survivors and invasive mechanically ventilated and non-
invasive mechanically ventilated patients.
Variables Mortality Mechanical ventilation
Survivors (n= 26) Non survivors (n= 4) P Non-IMV (n= 13) IMV (n= 17) P
Age 66.76 ± 7 77.5 ± 8 0.07 67.07 ± 6.5 69.05 ± 8.9 0.5
Sex (male) 19 (90.5%) 2 (9.5%) 0.6 9 (42.9%) 12 (57.1%) 0.94
P/Y smoking 57.13 ± 37.4 91.3 ± 28 0.15 52.62 ± 41 67.67 ± 34 0.37
No. Ex last year a 2.68 ± 2.25 1.75 ± 0 .96 0.2 2.5 ± 2 2.6 ± 1.7 0.96
Dyspnea (G IV)b 15 (88.2%) 2 (11.8%) 1 7 (41.2%) 10 (58.8%) 0.79
Severe current Ex 16 (88.9%) 2 (11.1%) 1 4 (22.2%) 14(77.8%) 0.004
Pneumonia 9(75%) 3(25%) 0.27 5(41.7%) 7(58.3%) 0.88
Hypertension 9 (81.8%) 2(18.2%) 0.61 4(36.4%) 7 (63.6%) 0.71
Renal impairment 0(0%) 2(100%) 0.01 0(0%) 2(100%) 0.49
Heart rate 99.27 ± 17.7 105 ± 23.8 0.67 99.69 ± 20.6 100.29 ± 16.9 0.93
Arrhythmia 3 (11.5%) 1 (25%) 0.5 1 (23.1%) 3 (5.9%) 0.3
Respiratory rate 27.8 ± 5 25.5 ± 6.8 0.56 25.92 ± 3.8 28.75 ± 6.1 0.14
Temperature 37.38 ± 0.7 37.57 ± 0 .8 0.68 37.30 ± 0 .7 37.49 ± 0 .6 0.45
SBP 131.15 ± 19.4 125 ± 33 0.74 131.54 ± 16.7 129.41 ± 24.4 0.77
DBPa 81.53 ± 10.5 70 ± 14.1 0.24 82.3 ± 10.9 78.2 ± 11.9 0.32
MAP 98.1 ± 12.8 88.3 ± 20.1 0.4 98.7 ± 12.5 95.3 ± 15.2 0.5
GCSa 14.3 ± 2 15 ± 0 0.15 15 ± 0 14.06 ± 2.4 0.15
Urinary out put 1996.2 ± 1000 1000 ± 743.8 0.07 1776.9 ± 521 1929.4 ± 906 0.57
LOS in ICUa 7.7 ± 3.7 19.3 ± 14.2 0.18 6.7 ± 3.4 11.2 ± 8.9 0.210
LOS in hospital 12.06 ± 4.4 22 ± 17.4 0.04 9.2 ± 3 15.66 ± 9.7 0.03
IMV durationa 2.18 ± 2.7 18 ± 13.4 0.05 0.0 ± 0 7.4 ± 8 <0.001
FiO2a 0.25 ± .08 0.31 ± .14 0.48 0.25 ± .07 0.26 ± .1 0.84
PH 7.26 ± 0 .07 7.27 ± 0.05 0.83 7.3 ± 0.03 7.23 ± 0.07 0.003
PaCO2 mmHg 82.45 ± 18.2 73.25 ± 20.4 0.45 78.68 ± 12.9 83.17 ± 21.9 0.49
PaO2 mmHg 59.58 ± 33.3 46.75 ± 5.9 0.08 60.7 ± 25.4 55.70 ± 35.7 0.66
HCO3 37.65 ± 8.4 30 ± 0.8 0.08 40.91 ± 6.6 33.54 ± 8 0.01
Oxygen saturation%a 77.4 ± 16.5 81.8 ± 4.6 0.16 81.5 ± 14.5 75.3 ± 16 0.31
PaO2/ FiO2a 245.2 ± 144.1 172.3 ± 85.7 0.22 240 ± 68.9 232 ± 175.1 0.37
Previous MV 8 (100%) 0 (0%) 0.55 2 (25%) 6 (75%) 0.24
Sepsis 2 (50%) 2 (50%) 0.07 2 (50%) 2 (50%) 1
Mortality – – – 0 (0%) 4 (100%) 0.11
IMV 13 (76.5%) 4 (23.5%) 0.11 – – –
SAPS II 30.6 ± 6.1 37.75 ± 9.5 0.23 28.5 ± 4.4 33.9 ± 7.6 0.02
IMV: invasive mechanical ventilation; Ex: exacerbation, SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial
pressure; GCS: Glasgow Coma Score; LOS: length of stay; FiO2: fraction of inspired oxygen; PaO2: partial arterial oxygen pressure; PaCO2:
partial arterial carbon dioxide pressure; pH: arterial blood pH; SAPS II: Simpliﬁed Acute Physiology Scores II.
Qualitative data were compared using Chi-square or Fisher’s exact when appropriate. Quantitative data were compared using independent t-
test.
a Non parametric data were converted into parametric by log transformation and mean ± SD of the original data was expressed.
b Dyspnea grade IV is according to Medical Research Council (MRC) dyspnea scale [24].
396 A.M. Madkour, N.N. Adlyspeciﬁcity, positive and negative predictive values for predicting
the need for IMV of 76%, 92%, 93% and 75%, respectively
(Table 4).
ROC curve was plotted for studying the accuracy of SAPS
II in prediction of IMV and result is shown in Fig. 2. ROC
curve showed that SAPS II has a moderate predictive capabil-
ity with area under the ROC curve (AUC) of 0.729 with a cut-
off ofP31 having sensitivity, speciﬁcity, positive and negative
predictive values for predicting the need for IMV of 70.6%,
76.9%, 80% and 66.7%, respectively (Table 4). Pair-wise
comparison between AUCs of both predicted equation and
SAPS II (using medcalc program) revealed a signiﬁcant differ-
ence P= 0.049; therefore; predicted equation is better than
SAPS II in prediction of IMV.
The DA showed that the presence of renal impairment, pre-
vious history of hypertension, pneumonia, sepsis and lower
glucose level were signiﬁcant predictors of mortality and dis-criminant equation for prediction of mortality was constructed
(Table 5).
ROC curve was plotted for studying the accuracy of the
predicted equation in the prediction of mortality and result
is shown in Fig. 3. ROC curve showed that the predicted equa-
tion has a moderate predictive capability with AUC of 0.942
(P= 0.005) with a cut-off of P11.4388 having sensitivity,
speciﬁcity, positive and negative predictive values for predict-
ing mortality of 100%, 89%, 57% and 100%, respectively.
Studying the accuracy of SAPS II in prediction of mortality
showed no signiﬁcant results (P= 0.143) in elderly COPD
patients presenting with AHRF.
Discussion
This study reveals that the in-hospital morality was 13.3% all
of whom died in ICU and had IMV. Renal impairment, previ-
Table 3 DA for prediction of IMV.
Discriminant function
Variables Function
Sepsis 3.755
Pack year smoking 0.038
Severe current exacerbation 3.773
SAPSII 0.174
pH 9.492
Constant 57.971
DA: discriminant analysis; IMV: invasive mechanical ventilation.
SAPS II: Simpliﬁed Acute Physiology Scores II.
pH: arterial blood pH.
Predicted equation of IMV= (sepsis \ 3.755) + (pack
year \ 0.038) + (severe current exacerbation \ 3.773) + (SAPS
II \ .174) + ((pH \ (9.492)) + 57.971.
Fig. 1 ROC curve of predicted equation in prediction of IMV.
The area under curve (AUC): 0.878 and the choice of cut-off is
P1.1728.
Fig. 2 ROC curve for SAPS II score in prediction of IMV. The
area under curve (AUC): 0.729 and the choice of cut-off is P31.
Table 5 DA for prediction of mortality.
Discriminant function
Variables Function
Renal impairment 29.436
Hypertension 3.491
Pneumonia 1.948
Sepsis 30.570
Lower glucose level 25.160
Constant 44.964
DA: discriminant analysis.
Predicted equation of mortality = (renal impairment \ 29.436) +
+(hypertension \ 3.491) + (pneumonia \ 1.948) + (sepsis \ 3057)
+ (lower glucose level \ (25.160)) + 44.964.
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cose level were signiﬁcant predictors of mortality and discrim-
inant equation for the prediction of mortality had 94.2%
accuracy, sensitivity, speciﬁcity, positive and negative predic-
tive values for predicting death of 100%, 89%, 57% and
100%, respectively.
In the current study, the incidence need for IMV was
56.7%. Sepsis, pack year smoking, severe current exacerba-
tion, SAPS II and lower pH were signiﬁcant predictors of
IMV and discriminant equation for prediction of IMV had
87.8% accuracy and having sensitivity, speciﬁcity, positiveTable 4 Results of ROC curves in prediction of IMV.
Variables Cutoﬀ Sens. (%) Spec. (%
Predicted equation P1.1728 76 92
SAPS II P31 70.6 76.9
ROC: receiver operating characteristic; IMV: invasive mechanical ventilat
NPV: negative predicted value; AUC: area under curve.and negative predictive values for predicting need for MV of
76%, 92%, 93% and 75%, respectively.
Previous studies evaluating the mortality for AECOPD
have shown a wide range of ﬁgures. Low morality rate
(13.3%) in the current study was in line with those of other re-
ports [13,14]. Connors et al. [14] and Fuso et al. [13] reported
an in-hospital mortality of 11% and 14.4%, respectively.
Higher mortality rates (25.2% and 33.1%) were recorded by
Mohan et al. [27] and Ucgun et al. [8] respectively. Weiss
and Hudson [23] reviewed 11 studies carried out to study the
outcome of patients with exacerbation of COPD and found
the combined mortality rate to be 20.3%. Differences in dis-
ease severity and diversity of the patient’s selection in each
study may partly explain the variations in mortality ﬁgures [8].) PPV (%) NPV (%) AUC P
93 75 0.878 <0.001
80.0 66.7 0.729 0.035
ion; Sens.: sensitivity, Spec.: speciﬁcity, PPV: positive predicted value;
Fig. 3 ROC curve of predicted equation in prediction of
mortality. The area under curve (AUC): 0.942 and the choice of
cut-off is P11.4388.
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with acute RF [8]. Reports on incidence need of IMV in pa-
tients with exacerbation of COPD is variable ranging between
9.8% and 84% [23,28]. In the current study, 56.7% of the pa-
tients underwent IMV. Comparable incidence need for IMV
(57.6%) was reported by Ucgun et al. in similar COPD popu-
lation presenting with AHRF to Respiratory ICU having a
mean age of 65.1 years [8].
Studies aimed at developing clinical prediction tools to im-
prove predicting mortality in AECOPD at the time of admis-
sion are scant and there remains a need for a more objective
way of prognosticating patients particularly in elderly COPD
and those presenting with respiratory failure. Derived equa-
tions have been used previously by some authors [27] as in
the current study aiming to provide a useful, simple, easily
applicable index for prognostication and risk stratiﬁcation.
However, Mohan et al. study was not speciﬁc to hypercapnic
COPD patients [27]. The current study identiﬁed several pre-
dictors of in-hospital mortality (Table 5). Predictors in other
studies such as serum creatinine [27–30], sepsis [12,28,31],
pneumonia [32,33] linked to an increased risk of in-hospital
mortality in AECOPD (without age or AHRF speciﬁcations)
were comparable to the present study predictors, but in elderly
COPD presenting with AHRF.
The role of pneumonia as the predictor of morality among
AECOPD has been previously noted by Lieberman et al. [34]
and Restrepo et al. [35] in agreement with the present study,
but in nonelderly populations. Lieberman et al. [34] evaluated
and compared exacerbations in patients with COPD with and
without pneumonia, and found that those with pneumonia had
a more severe illness, longer LOS, and higher rates of ICU
admission and mortality.
Blood glucose is of emerging importance recently in COPD
exacerbations [36].
It has been previously emphasized that lower glucose levels
were associated longer hospitalization and 90-day all-cause
mortality in patients with AECOPD [37]. In agreement, lower
glucose levels were a predictor of mortality among elderly
COPD presenting with AHRF in the present study. Olderage can increase the risk of developing lower glucose levels be-
cause of the higher rate of comorbidities (e.g. renal failure or
malnutrition) and elder hospitalized patients often experience
failure of regulatory mechanisms, especially in stress situa-
tions, such as reduced release of glucagon and epinephrine in
response to hypoglycemia [38]. Several previous studies [38–
40] had conﬁrmed that hypoglycemia was a predictor of in-
hospital morality in elderly hospitalized patients as in the pres-
ent study.
Very little is known about the relative impact of arterial
hypertension on COPD morality [41]. In one study, hyperten-
sion has been previously found to be a predictor of cardio-
vascular mortality outside hospital in elderly patients with
stable COPD [41]. In another study, hypertension was the
predictor of mortality within 3 months after hospital dis-
charge in 606 COPD patients that were admitted with exac-
erbation, and 63.4% of them were hypertensive [42]. In our
study, hypertension was the predictor to in-hospital mortality
in elderly COPD population presenting with AHRF. Thus,
emphasizing the importance of hypertension in relation to
COPD mortality particularly in the elderly group. In elderly,
the following facts may explain such importance: hyperten-
sion represents the main co-morbid condition in elderly
[43], the coexistence of hypertension and old age increases
per se the risk of cardiovascular mortality due to long-term
exposure to common risk factor [44], combined presence of
COPD and hypertension in elderly seems quite common
[44]and elderly COPD with hypertension have a lower use
of anti-hypertensive drugs [45]. Furthermore, COPD subjects
are frequently treated with drugs such as corticosteroids and
B2 stimulating agents that limit the effect of some anti-hyper-
tensive drugs [41].
Age of patients with COPD has been found to be a predic-
tor of in-hospital mortality by some investigators [12–15] while
alike the present study others reported that age was not a pre-
dictor of COPD outcome [10,17,29]. Absence of age as a pre-
dictor of mortality, while the presence of variables such as
renal impairment, hypertension, sepsis or pneumonia as pre-
dictors of mortality, reﬂects the importance of comorbidities
associated with age rather than the chronological age alone
[46]. The chronological age could be surrogate for factors
reﬂecting complicated disease, but not an independent predic-
tor of disease speciﬁc mortality [47].
In the present study, hypercapnia on admission has not
been shown to be a predictor of morality in agreement with
other previous studies [12,13,32,48]. However, other studies
conﬁrmed that the severity of hypercapnia on admission is
more clearly related to long-term mortality [7,49]; in which
individuals with hypercapnia at admission and discharge had
signiﬁcantly higher 5-year mortality rates than those in whom
hypercapnia resolved during their hospital stay [50].
Although IMV is associated with higher mortality rates, it
was not a predictor of in-hospital mortality in the current
study. This is also similar to the ﬁndings by Seneff et al.[51]
and Afessa et al. [12].
The current study identiﬁed several predictors of IMV (Ta-
ble 3). Finding of pH as a predictor of need of IMV in the pres-
ent study is in consonance with earlier studies.[4,28,52]. Even
that one study postulated that patients with pH < 7.26 were
almost ﬁve times more likely to the need of IMV [28].
Known effect of both smoking and exacerbation severity on
spirometric indices in COPD helps in explaining their role as
Predictors of in-hospital mortality and need for invasive mechanical ventilation in elderly COPD patients 399predictor of IMV [53]. Vitacca et al., found that spirometric
indices predict the need for IMV in patients presenting with
an exacerbation of COPD [54].
Elderly patients with severe sepsis and septic shock often re-
quire IMV [55]. Sepsis as a predictor of IMV in the current
study could be attributed to the signiﬁcance of IMV in sepsis
even without respiratory compromise due to that the respira-
tory muscles are avid consumers of oxygen and can use up to
50% of circulating oxygen. Intubation and paralysis not only
increase available oxygen to vital organs, but can also augment
cardiac output for patients with persistent septic shock [56].
The predicted equation was better than SAPS II alone to
predict IMV. This could be attributed to the fact that general
illness severity scores like SAPS II are not disease speciﬁc tools
and that disease-speciﬁc prognostic scoring is warranted.
This study has several limitations. The study was done in a
relatively small sample in one center with little observed mor-
tality. Thus, a larger series would be able to evaluate the prog-
nostic factors and to relate these to prediction of mortality
risk. Unfortunately we did not have the opportunity to follow
our patients after hospital discharge.
We concluded that elderly COPD patients presenting with
AHRF are at risk for in-hospital morality. Renal impairment,
previous history of hypertension, pneumonia, sepsis and lower
glucose level were signiﬁcant predictors of mortality while, sep-
sis, pack year smoking, severe current exacerbation, SAPS II
and lower pH were signiﬁcant predictors of IMV need. The
equations derived by combining these parameters are useful
for identifying patients that are likely to have a poor outcome
or need for IMV. However, due to the study limitations these
ﬁndings should be validated by later larger studies.Conﬂict of interest
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